For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Scope of the Report:
Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with severe bacterial infection. PCT is therefore an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions.
Expressed in E.coli, PCT can be used as a reagent to prepare calibrators for procalcitonin or calcitonin immunoassays.
The global procalcitonin market had reached 126.4 g in 2016 and is expected to increase reach 212.6 g by 2023. In terms of revenue, the global procalcitonin chloride market was valued 61.85 Million USD in 2016, and is estimated to be worth 92.27 Million USD by 2023. Overall, the procalcitonin products performance is positive with the global economic recovery.
The manufacture region is concentrated in USA, Europe, China and Japan, of which Europe is the largest region with the share 36.92% in 2016. The production shares of Europe, China and Japan were 23.07%, 19.12% and 6.43%.
The consumption share of North America, Europe, Asia Pacific were 26.73%, 28.27%, 35.77% in 2016. Asia Pacific is the main export region.
There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in Procalcitonin market will become more intense.
The worldwide market for Procalcitonin (CAS 56645-65-9) is expected to grow at a CAGR of roughly 6.4% over the next five years, will reach 90 million US$ in 2024, from 62 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Procalcitonin (CAS 56645-65-9) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Thermo Fisher
- Roche Diagnostics
- bioMerieux
- HyTest
- BBI Solutions
- ProSpec
- Wondfo
- Ningbo Medicalsystem Biotechnology
- Wuhan Easy Diagnosis Biomedicine
- Snibe
- Vazyme Biotech
- Getein Biotech
- Hotgen Biotech
- Lumigenex
- Nanjing Norman Biological Technology
- Shanghai Medicine'nest Pharmaceutical
- Kitgen
- Beijing KeyGen
- Beijing Apis
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Procalcitonin Antigen
- Procalcitonin Antibody
Market Segment by Applications, can be divided into
- Medical Industry
- Scientific Research
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Procalcitonin (CAS 56645-65-9) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Procalcitonin (CAS 56645-65-9), with price, sales, revenue and global market share of Procalcitonin (CAS 56645-65-9) in 2017 and 2018.
Chapter 3, the Procalcitonin (CAS 56645-65-9) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Procalcitonin (CAS 56645-65-9) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Procalcitonin (CAS 56645-65-9) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Procalcitonin (CAS 56645-65-9) sales channel, distributors, customers, research findings and conclusion, appendix and data source.